In a landmark development for U.S. antitrust law, on October 10 the commissioners of the Federal Trade Commission (the “FTC”) unanimously adopted a final rule (the “Final Rule”) that significantly revises the implementing regulations under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (the “Act”). The Final Rule represents the most comprehensive update to the Act’s requirements in nearly five decades. Scheduled to take effect in January 2025, the Final Rule will reshape the disclosure landscape by expanding both the scope and depth of required information, demanding additional preparation time and supporting documentation from the parties to reportable transactions.
Historical Context of the Act
Since its enactment, the Act has required parties involved in covered transactions to submit premerger filings to the FTC and the Department of Justice (collectively, the “Agencies”) for antitrust review. The review process has historically focused on identifying competitive risks by examining overlapping products, services and markets between merging entities. Each party that is required to file must submit an HSR Form detailing key aspects of the transaction and its business operations, initiating a mandatory 30-day waiting period during which the Agencies determine whether the transaction presents any antitrust risks.
Traditionally, the core framework of the Act has remained stable. However, the recent overhaul introduces substantial changes, reflecting the Agencies’ aim to secure more comprehensive disclosures and earlier access to critical data. The Final Rule expands the scope of required information to include new subject areas not covered in previous filings, enabling regulators to apply more rigorous scrutiny throughout the review process.
Key Changes Under the Final Rule
The Final Rule requires both acquirers and targets to disclose acquisitions from the five years before the filing, whereas the existing rules place this responsibility only on acquirers. This change reflects the Agencies’ focus on potentially anti-competitive “roll-up” strategies by private equity firms and other repeat acquirers.
The FTC will reinstate the early termination option for the statutory 30-day waiting period, potentially speeding up transaction timelines for deals where the Agencies have completed their review and determined they will not take any enforcement action during the waiting period.
Implications for Businesses
With the expanded filing requirements, businesses must anticipate longer lead times for preparation. The FTC estimates that each party may require up to 121 hours of preparation for complex transactions involving competitors or pre-existing supply relationships, highlighting the importance of early planning and thorough antitrust risk assessments.
Notably, while the revised rules increase filing burdens, they are less onerous than initially proposed. The FTC abandoned some features that were contained in the proposed regulations such as geolocation information and expansive narrative disclosures.
To mitigate the compliance burden, businesses involved in M&A transactions should engage antitrust counsel early to assess the reporting obligations and allocate sufficient time to meet the heightened compliance demands under the Final Rule.
Conclusion
The changes to the Act’s implementing regulations reflect the Agencies’ goal of securing greater insight into transactions at earlier stages. While the reinstatement of early termination will offer some relief in uncontroversial transactions, the increased scrutiny and documentation requirements necessitate careful planning. Proactive engagement with experienced antitrust counsel will be critical to navigating these changes and minimizing potential risks.
A complete copy of the FTC release regarding the Final Rule can be found here. The FTC press release announcing the Final Rules can be found here. Our team will continue to monitor developments in this area and provide updates as necessary. If you have any questions, feel free to contact any member of the Corporate & Securities practice group.
NOTICE.
Although we would like to hear from you, we cannot represent you until we know that
doing so will not create a conflict of interest. Also, we cannot treat unsolicited
information as confidential. Accordingly, please do not send us any information
about any matter that may involve you until you receive a written statement from
us that we represent you (an ‘engagement letter’).
By clicking the ‘ACCEPT’ button, you agree that we may review any information you transmit to us. You recognize that our review of your information, even if you submitted it in a good faith effort to retain us, and, further, even if you consider it confidential, does not preclude us from representing another client directly adverse to you, even in a matter where that information could and will be used against you. Please click the ‘ACCEPT’ button if you understand and accept the foregoing statement and wish to proceed.